These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6799366)

  • 1. [Studies of D-penicillamine (5): effects on rat adjuvant arthritis (author's transl)].
    Otomo S; Higuchi S; Nakaike S; Tarumoto Y; Kimura M; Sasajima M; Ohzeki M
    Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):145-62. PubMed ID: 6799366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of D-penicillamine on strain variability and lymph node cellularity in adjuvant arthritis.
    Nakaike S; Takeshita K; Shiono M; Tomita N; Otomo S; Aihara H
    Agents Actions; 1985 Sep; 16(6):514-20. PubMed ID: 3934925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action (author's transl)].
    Fujimura H; Hiramatsu Y; Tamura Y; Yanagihara M; Koda A; Nagai H; Uda K; Iso T; Yamauchi H
    Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):117-29. PubMed ID: 6249702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of D-penicillamine on vitamin B6 and metal ions in rats (author's transl)].
    Otomo S; Sasajima M; Ohzeki M; Tanaka I
    Nihon Yakurigaku Zasshi; 1980 Jan; 76(1):1-13. PubMed ID: 7380358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat adjuvant arthritis as a model to test potential antirheumatic agents.
    Toivonen ML; Tokola O; Vapaatalo H
    Methods Find Exp Clin Pharmacol; 1982; 4(6):359-63. PubMed ID: 7144330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of D-penicillamine (4) : effects on antibody formation (author's transl)].
    Otomo S; Takeshita K; Koda H; Ohzeki M
    Nihon Yakurigaku Zasshi; 1981 Jul; 78(1):45-56. PubMed ID: 6796481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.
    Connolly KM; Stecher VJ; Danis E; Pruden DJ; LaBrie T
    Agents Actions; 1988 Aug; 25(1-2):94-105. PubMed ID: 3142230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the influence of cyclophosphamide, gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis.
    Arrigoni-Martelld E; Bramm E
    Agents Actions; 1975 Aug; 5(3):264-7. PubMed ID: 829840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies of antigen-induced arthritis in BALB/c mice. II. The effects of second-line antirheumatic drugs and cytotoxic agents on the histopathological changes.
    Hunneyball IM; Crossley MJ; Spowage M
    Agents Actions; 1986 Jun; 18(3-4):394-400. PubMed ID: 2875633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of D-penicillamine (3): immunomodulating effects of D-penicillamine.
    Otomo S; Nakaike S; Tsuji I; Mori C; Ohzeki M
    Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):313-20. PubMed ID: 6820351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal mu-opioid receptor expression and hyperalgesia with dexamethasone in chronic adjuvant-induced arthritis in rats.
    Zaringhalam J; Manaheji H; Mghsoodi N; Farokhi B; Mirzaiee V
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1309-15. PubMed ID: 18671722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the effect of anti-inflammatory and anti-rheumatoid drugs in cell-mediated immune arthritis in guinea-pigs by microfocal radiography.
    Cashin CH; Doherty NS; Jeffries BL; Buckland-Wright JC
    Br J Exp Pathol; 1980 Jun; 61(3):296-302. PubMed ID: 6775665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.
    Mirshafiey A; Cuzzocrea S; Rehm B; Mazzon E; Saadat F; Sotoude M
    Scand J Immunol; 2005 May; 61(5):435-41. PubMed ID: 15882435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats.
    Garrett IR; Whitehouse MW; Vernon-Roberts B; Brooks PM
    J Rheumatol; 1985 Dec; 12(6):1079-82. PubMed ID: 3937896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the effects of pharmacological agents on antigen-induced arthritis in BALB/c mice.
    Crossley MJ; Spowage M; Hunneyball IM
    Drugs Exp Clin Res; 1987; 13(5):273-7. PubMed ID: 2890505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic suppressor cells in adjuvant arthritic rats: effect of D-penicillamine.
    Binderup L; Bramm E; Arrigoni-Martelli E
    Agents Actions Suppl; 1980; 7():199-203. PubMed ID: 6454335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of interleukin 18 in indomethacin-induced lesions of the gastric mucosa in adjuvant-induced arthritis rat.
    Nagai N; Fukuhata T; Ito Y; Usui S; Hirano K
    Toxicology; 2009 Jan; 255(3):124-30. PubMed ID: 18996434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acids. Immunomodulating effects.
    Takeshita K; Fukazawa I; Futaki N; Kameo K; Tomisawa K; Otomo S; Aihara H
    Arzneimittelforschung; 1988 Apr; 38(4):537-42. PubMed ID: 3041971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early phase adjuvant arthritis on hepatic P450 enzymes and pharmacokinetics of verapamil: an alternative approach to the use of an animal model of inflammation for pharmacokinetic studies.
    Ling S; Jamali F
    Drug Metab Dispos; 2005 Apr; 33(4):579-86. PubMed ID: 15659540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.